ArticleCancer prevention research (Philadelphia, Pa.)2025
Lung Cancer Screening among Adults Older than Medicare's Upper Age Eligibility Criteria.
Article in Cancer prevention research (Philadelphia, Pa.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Implications on the loss of lung cancer screening (LCS) coverage among Medicare recipients aged 77+ years have not been explored. We use a 2022 Behavioral Risk Factor Surveillance System dataset to examine LCS patterns of screen-eligible adults across three age groups: 65 to 70, 71 to 77, and 78 to 79 years. In descriptive analyses, LCS-eligible respondents are compared by screening status across each age category. In regression analyses, we explore various sociodemographic and health-related factors that may help explain age-related differences between these groups. Less than a third of our sample reported LCS in the last year (26.3%). Among eligible respondents, adults aged 78 to 79 years reported the highest LCS rates (32.0%), followed by adults aged 71 to 77 years (28.3%) and 65 to 70 years (24.2%). Respondents aged 78 to 79 years and 65 to 70 years with chronic obstructive pulmonary disease indicated significantly increased LCS odds [OR, 3.37; 95% confidence interval (CI), 1.12-10.11 and OR, 2.91; 95% CI, 1.98-4.27, respectively]. Respondents aged 78 to 79 years with history of a heart attack or kidney disease indicated significantly decreased LCS odds (OR, 0.08; 95% CI, 0.01-0.62 and OR, 0.06; 95% CI, 0.01-0.56, respectively). Respondents aged 71 to 77 years with coronary heart disease indicated a significantly decreased LCS odds (OR, 0.54; 95% CI, 0.30-0.96). Although loss of Centers for Medicare & Medicaid Services coverage for LCS is not associated with lower screening among Behavioral Risk Factor Surveillance System adults aged 78 to 79 years, clinicians should continue to consider the appropriateness of treatment for older LCS-eligible adults with chronic health conditions. PREVENTION RELEVANCE: Persons who reach the age of 78 years are no longer eligible for LCS coverage from Medicare. This study fills an important knowledge gap by comparing LCS patterns among a nationally representative sample of Medicare-eligible adults aged 78 to 79 years with their younger counterparts aged 65 to 77 years, for whom Centers for Medicare & Medicaid Services covers LCS. See related Spotlight, p. 655.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.